2,4-Diaryl-4,6,7,8-tetrahydroquinazolin-5(1H)-one derivatives as anti-HBV agents targeting at capsid assembly

2,4-Diaryl-4,6,7,8-tetrahydroquinazolin-5(1H)-one derivatives as anti-HBV agents targeting at capsid assembly A new series of HAPs as anti-HBV agents targeting at capsid assembly Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives Structure–activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectors Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitro